Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Spink7 (serine peptidase inhibitor, Kazal type 7) Rattus norvegicus
Analyze
Symbol: Spink7
Name: serine peptidase inhibitor, Kazal type 7
Description: Predicted to have serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of endopeptidase activity. Predicted to localize to the extracellular region. Orthologous to human SPINK7 (serine peptidase inhibitor, Kazal type 7 (putative)); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine (ortholog); aflatoxin B1 (ortholog).
Type: protein-coding
RefSeq Status: INFERRED
Also known as: Ecg2; ECRG-2; Ecrg2; esophagus cancer-related gene 2 protein; esophagus cancer-related protein 2; serine peptidase inhibitor, Kazal type 7 (putative); serine protease inhibitor Kazal-type 7
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01857,916,369 - 57,920,169 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01857,142,773 - 57,146,245 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41858,606,632 - 58,610,104 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11858,679,832 - 58,683,305 (-)NCBI
Celera1854,191,433 - 54,194,905 (-)NCBICelera
Cytogenetic Map18q12.1NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated
RGD Disease Portals

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Spink7
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1303077
Created: 2004-12-03
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.